considerations and recommendations for sequencing therapy for her2 advanced breast cancer
Published 5 years ago • 15 plays • Length 4:00Download video MP4
Download video MP3
Similar videos
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
2:44
sequencing agents for her2 metastatic breast cancer
-
14:24
optimisation of treatment selection & sequencing decisions in er /her2- breast cancer
-
2:07
recommendations for her2 testing in metastatic breast cancer
-
7:44
treatment options for her2 breast cancer: a comprehensive guide
-
1:13
dr. chagpar on sequencing therapies for her2-positive breast cancer
-
3:32
sequencing novel her2-targeted therapies in metastatic breast cancer
-
2:24
breast cancer risk assessment: a vital tool for women
-
34:21
expanding options for her2 advanced breast cancer: taking trial data to the clinic
-
4:19
recommendations for her2 testing in breast cancer
-
46:00
advanced breast cancer: challenges in pathways development
-
34:12
new and emerging agents in her2-negative metastatic breast cancer: implications for practice
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
0:41
new drug approvals for metastatic breast cancer
-
0:58
treatment approach for metastatic her2 positive breast cancer
-
2:02
what treatments are available for her2-positive metastatic breast cancer?
-
1:01
dr. hamilton discusses challenges with approved treatments for her2-positive breast cancer
-
6:35
treatment for high- and low-risk her2 breast cancer
-
1:00
2nd line treatment options for hr breast cancer.